Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Guided Therapeutics Inc. (GTHP : OTC)

• Company Description    GUIDED THERAPEUTICS, Inc. is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tests. Unlike Pap and HPV tests, the device does not require a painful tissue sample and results are available immediately. GT also owns technology for measuring substances in interstitial fluid, a secondary circulatory system in the body that surrounds the cells. Number of Employees: 4

• Price / Volume Information    Yesterday's Closing Price: $0.27 Daily Weekly Monthly 20 Day Moving Average: 15,493 shares Shares Outstanding: 78.91 (millions) Market Capitalization: $20.95 (millions) Beta: 0.11 52 Week High: $0.30 52 Week Low: $0.06 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 101.90% 93.58% 12 Week 231.88% 190.81% Year To Date 77.00% 67.17%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5835 PEACHTREE CORNERS EAST SUITE B - PEACHTREE CORNERS,GA 30092 USA ph: 770-242-8723 fax: 770-242-8639 info@guidedinc.com http://www.guidedinc.com

• General Corporate Information    Officers Mark Faupel - Chief Executive Officer; President; Acting Chief F Michael C. James - Chairman and Director Richard P. Blumberg - Director John E. Imhoff - Director Alan Grujic - Director Peer Information Guided Therapeutics Inc. (BJCT) Guided Therapeutics Inc. (CADMQ) Guided Therapeutics Inc. (APNO) Guided Therapeutics Inc. (UPDC) Guided Therapeutics Inc. (IMTIQ) Guided Therapeutics Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 40171F501 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/13/25 Share - Related Items Shares Outstanding: 78.91 Most Recent Split Date: 3.00 (0.00:1) Beta: 0.11 Market Capitalization: $20.95 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 0.00% vs. Previous Quarter: 50.00% Sales Growth vs. Year Ago Period: -96.88% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - -197.32 12/31/24 - -179.97 Current Ratio 06/30/25 - - 03/31/25 - 0.14 12/31/24 - 0.19 Quick Ratio 06/30/25 - - 03/31/25 - 0.03 12/31/24 - 0.09 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - -244,200.00 12/31/24 - -34,528.57 Book Value 06/30/25 - - 03/31/25 - -0.09 12/31/24 - -0.12 Inventory Turnover 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.01 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©